NEW YORK, April 23 - Richard Groves has been named business development director for the new European office of life sciences grid computing provider TurboWorx, the
Steven Ruben has been appointed vice president of protein therapeutics for Celera Genomics, the company said April 17.
Ruben, who will oversee the company's target validation efforts as well as protein chemistry, cell biology, and mass spectrometry research, comes to Celera from
Goran Ando has been named new CEO of UK biotech giant Celltech, which just acquired Oxford Glycosciences in a cash tender offer, the company said April 16.
Ando comes to Celltech from Pharmacia, where he was president of R&D until the company was acquired by Pfizer April 15. Ando has also served as director of R&D for Glaxo Group Research.
Ando replaces Peter Fellner, the CEO of Celltech since 1990. Fellner will now serve as chairman of Celltech.